-
UK set for cautious budget as borrowing costs climb
-
Afghans compete for jobs, homes as millions return
-
Anthropic's record IPO faces some big questions
-
'They don't care about us': Trump food aid cuts leave Americans struggling and angry
-
US Fed expected to hold rates steady ahead of key midterm elections
-
Meta, Snap head to trial in another case about social media's harms
-
Can this Latin Grammy-winner help Democrats win back Congress?
-
French Senate passes bill to make protesters pay for unrest damage
-
Tuvalu has 'limited' power to halt its fossil fuel investments: NZ govt papers seen by AFP
-
India evacuates tens of thousands as Cyclone Arnab makes landfall
-
Palestinian activist Khalil returns to Columbia after US detention
-
In tight Israel vote, both camps hold out cautious hope
-
Trump drastically loosens oil and gas methane rules
-
AI chip giant SK hynix says quarterly operating profit soars 630%
-
French Senate weighs bill to make protesters pay for unrest damage
-
Youths testify about 'despair' in unprecedented Canadian climate trial
-
'A very sad day': Arteta despair as Arsenal stunned by Fleetwood
-
Syria, Jordan agree to mend ties after deadly strike
-
Charles tackles thorny legacy of slavery on Caribbean trip
-
Arsenal stunned by fourth-tier Fleetwood in League Cup
-
Former Grand Slam winner Wawrinka ends tennis career
-
Last-gasp Sabitzer strike sends Dortmund past Bremen in German Cup
-
Brazil's Flavio Bolsonaro flees to US after election loss
-
Rights groups reject Emirati diplomat for UN top job
-
'Faerie' nights: 'ACOTAR' fans finally get their book
-
Flavio Bolsonaro headed to US after Brazil election defeat: US media
-
American woman convicted of getting military training from Islamic State
-
Alcaraz and Zverev win Vienna openers
-
Israel opposition holds narrow edge over Netanyahu in first projections
-
Tech firms gain ahead of Fed decision, results from AI giants
-
Floriani hits maiden goal as Lazio go top
-
Syria condemns deadly Jordan strikes as 'unacceptable violation'
-
Trump set to drastically loosen oil and gas sector's methane rules
-
England's Fin Smith in race against time to face Australia
-
Storied Paris department store seeks bankruptcy protection
-
UN nuclear watchdog chief urges Iran to grant access
-
Xhaka, Embolo can return to Swiss squad after fake Covid docs affair
-
Boeing shares tumble after it releases cautious growth forecast
-
Allegri suspended for two Serie A games after red card
-
Lula's re-election revives Brazil-US tensions
-
Flight data, satellite images reveal growing US role at Ecuador base
-
Carney moves to remake Canada alliances as US ties strained
-
McInnes feels 'guilt' ahead of Hearts return with Rangers
-
Serbia's students demand state media chiefs resign after poll win
-
Brazil's Lula turns 81, vows to work '24 hours a day'
-
Starc takes six as Australia fight back in South Africa decider
-
Boeing releases cautious growth plan as shares fall sharply
-
UK man offered drugged wife to strangers online for sex: court
-
Exiled Russian dissident Navalnaya warns dictators becoming 'more cunning'
-
Africa Ebola outbreak passes 10,000 cases, mostly in DR Congo
Scientists clone first rhesus monkey using new method
Scientists in China on Tuesday announced that they have cloned the first healthy rhesus monkey, a two-year-old named Retro, by tweaking the process that created Dolly the sheep.
Primates have proved particularly difficult to clone, and the scientists overcame years of failure by replacing the cloned cells that would become the placenta with those from a normal embryo.
They hope their new technique will lead to the creation of identical rhesus monkeys that can be experimented on for medical research.
However, outside researchers warned that the success rate for the new method was still very low, as well as raising the usual ethical questions around cloning.
Since the historic cloning of Dolly the sheep using a technique called somatic cell nuclear transfer (SCNT) in 1996, more than 20 different animals have been created using the process, including dogs, cats, pigs and cattle.
However it was not until two decades later that scientists managed to clone the first primates using SCNT.
A pair of identical crab-eating macaques named Hua Hua and Zhong Zhong were created using SCNT in 2018 by researchers at the Chinese Academy of Sciences Institute of Neuroscience in Shanghai.
But that breakthrough, led by the institute's Qiang Sun, only resulted in live births in fewer than two percent of attempts.
Qiang was also a senior author of the new research published in the journal Nature Communications.
He told AFP that the team had extensively researched why previous efforts to clone the rhesus monkey (Macaca mulatta) had failed.
In an earlier attempt, one monkey -- out of 35 implanted foetuses -- was born alive, but it died in less than a day.
Qiang said that one of the "major problems" was that the placentas of cloned embryos were showing abnormalities compared to those from in vitro fertilisation.
So the researchers replaced the cells that later become the placenta, which are called the trophoblast, with those from a healthy, non-cloned embryo.
The trophoblast cells provide nutrients to a growing embryo, and turn into the placenta that supplies oxygen and other life-supporting assistance to the foetus.
The technique "greatly improved the success rate of cloning by SCNT" and led to the birth of Retro, Qiang said.
- Human cloning 'unacceptable' -
However Lluis Montoliu, a scientist at the Spanish National Centre for Biotechnology who was not involved in the research, pointed out that just one out of 113 initial embryos survived, meaning a success rate of less than one percent.
If human beings were to ever be cloned -- the great ethical fear of this field of research -- then other primate species would have to be cloned first, he said.
But so far, the poor efficiency of these efforts has "confirmed the obvious: not only was human cloning unnecessary and debatable, but if attempted, it would be extraordinarily difficult -- and ethically unjustifiable," Montoliu said.
Qiang emphasised that cloning a human being was "unacceptable" in any circumstance.
For the SCNT procedure, scientists remove the nucleus from a healthy egg, then replace it with another nucleus from another type of body cell.
The embryo therefore grows into the same creature that donated the replacement nucleus.
A rhesus monkey named Tetra was cloned in 1999 using a different technique called embryo splitting.
But this simpler technique can only produce four clones at once.
Scientists have focused on SCNT in part because it can create far more clones, with the goal of creating identical monkeys to study a range of diseases as well as test drugs.
F.Stadler--VB